[go: up one dir, main page]

CN104803861B - Method for synthesizing tapentadol hydrochloride - Google Patents

Method for synthesizing tapentadol hydrochloride Download PDF

Info

Publication number
CN104803861B
CN104803861B CN201410038975.3A CN201410038975A CN104803861B CN 104803861 B CN104803861 B CN 104803861B CN 201410038975 A CN201410038975 A CN 201410038975A CN 104803861 B CN104803861 B CN 104803861B
Authority
CN
China
Prior art keywords
formula
methyl
reaction
sodium
benzyls
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410038975.3A
Other languages
Chinese (zh)
Other versions
CN104803861A (en
Inventor
刘振德
高河勇
毕鹏飞
周瑾
仇文军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biobond Pharmaceutical Co ltd
Original Assignee
Shanghai Bo Bang Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Bo Bang Pharmaceutical Technology Co Ltd filed Critical Shanghai Bo Bang Pharmaceutical Technology Co Ltd
Priority to CN201410038975.3A priority Critical patent/CN104803861B/en
Publication of CN104803861A publication Critical patent/CN104803861A/en
Application granted granted Critical
Publication of CN104803861B publication Critical patent/CN104803861B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种合成盐酸他喷他多的方法,其包括如下反应路线:其中的R1为卤素、‑OH、‑OR4、‑NO2、‑NH2、‑NR5R6、‑SH、‑SR7中的一种。本发明通过手性催化的方式,通过反应直接得到所要的手性异构体,避免了因手性拆分而产生的大量废弃物和环保问题,不仅整个路线短,而且操作简单,易于工业化,并且原料利用率高,大大提高了收率,降低了成本,符合工业化生产盐酸他喷他多的要求,具有显著性进步。The invention discloses a method for synthesizing tapentadol hydrochloride, which comprises the following reaction scheme: Wherein R 1 is one of halogen, -OH, -OR 4 , -NO 2 , -NH 2 , -NR 5 R 6 , -SH, -SR 7 . The present invention directly obtains the desired chiral isomer through reaction through chiral catalysis, avoiding a large amount of waste and environmental protection problems caused by chiral resolution, not only the whole route is short, but also simple to operate and easy to industrialize. Moreover, the raw material utilization rate is high, the yield is greatly improved, and the cost is reduced, which meets the requirements of industrial production of tapentadol hydrochloride, and has significant progress.

Description

一种合成盐酸他喷他多的方法A method for synthesizing tapentadol hydrochloride

技术领域technical field

本发明涉及一种合成盐酸他喷他多的方法,属于药物合成技术领域。The invention relates to a method for synthesizing tapentadol hydrochloride, which belongs to the technical field of medicine synthesis.

背景技术Background technique

盐酸他喷他多(Tapentadol Hydrochloride)的化学名称是(1R,2R)-3-(3-二甲基氨基-1-乙基-2-甲基丙基)苯酚盐酸盐,其化学结构式如下:The chemical name of Tapentadol Hydrochloride is (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol hydrochloride, and its chemical structure is as follows :

盐酸他喷他多是由德国Grunenthal公司研发的一种新颖的作用于中枢神经系统的口服止痛药物。它于2008年首次上市,用于缓解中度及重度急性疼痛。它具有阿片μ受体激动和去甲肾上腺素重吸收抑制双重作用机制。Tapentadol hydrochloride is a novel oral analgesic drug that acts on the central nervous system developed by the German company Grunenthal. It was first marketed in 2008 for the relief of moderate and severe acute pain. It has dual mechanisms of opioid μ receptor agonism and norepinephrine reuptake inhibition.

根据相关文献报道,盐酸他喷他多的合成路线目前主要有以下几种:According to relevant literature reports, the synthetic routes of tapentadol hydrochloride mainly contain the following types at present:

路线1(见欧洲专利文献EP0693475):Route 1 (see European patent document EP0693475):

该路线是以1-(二甲胺基)-2-甲基-3-戊酮和间溴苯甲醚为起始原料,经格氏反应得到4个手性异构体,需经手性柱分离得到所要的单一构型的中间体,再经氯化亚砜氯代、硼氢化锌还原、脱甲基、成盐得到单一构型的盐酸他喷他多,合成步骤较长,操作较繁琐,收率低,尤其是手性异构体的分离需要用手性柱,难以实现工业化生产。This route takes 1-(dimethylamino)-2-methyl-3-pentanone and m-bromoanisole as starting materials, and obtains 4 chiral isomers through the Grignard reaction, which need to pass through a chiral column. Separation of the desired single-configuration intermediate, and then chlorination by thionyl chloride, reduction by zinc borohydride, demethylation, and salt formation to obtain tapentadol hydrochloride of a single configuration. The synthesis steps are long and the operation is cumbersome. , the yield is low, especially the separation of chiral isomers requires a chiral column, which is difficult to achieve industrial production.

路线2(见国际专利文献WO2008016047、中国专利文献CN101495445及欧洲专利文献EP2046724):Route 2 (see international patent document WO2008016047, Chinese patent document CN101495445 and European patent document EP2046724):

该路线使用间甲氧基苯丙酮为起始原料,利用二甲胺盐酸盐与甲醛的Mannich反应,得到消旋的3-二甲氨基-1-(3-甲氧基苯基)-2-甲基丙酮中间体,再利用手性拆分剂拆分得到所要的S-3-二甲氨基-1-(3-甲氧基苯基)-2-甲基丙酮中间体,再经过格氏反应、消除、催化加氢、蛋氨酸脱除甲基等几步得到最终产物他喷他多。虽然该路线可以大大提高所要的异构体的比例,但仍然存在路线较长、成本高、容易产生很多意想不到的副产物和产生很多废弃物等缺陷问题,也难以工业化应用。This route uses m-methoxypropiophenone as a starting material, and utilizes the Mannich reaction of dimethylamine hydrochloride and formaldehyde to obtain racemic 3-dimethylamino-1-(3-methoxyphenyl)-2 -Methyl acetone intermediate, then use chiral resolving agent to resolve to obtain the desired S-3-dimethylamino-1-(3-methoxyphenyl)-2-methyl acetone intermediate, and then pass through grid The final product, tapentadol, is obtained through several steps such as reaction, elimination, catalytic hydrogenation, and demethylation of methionine. Although this route can greatly increase the ratio of the desired isomer, it still has defects such as long route, high cost, easy to produce many unexpected by-products and a lot of waste, and it is also difficult for industrial application.

路线3(见中国专利文献CN102002065A):Route 3 (see Chinese patent document CN102002065A):

该路线使用R-脯氨酸诱导间位取代苯甲醛与丙醛的不对称Aldol缩合,一步得到2个手性中心,将羟基磺酰化后格氏反应取代,最后脱除保护基得到所要产物。虽然该路线短,可以一步形成两个手性中心,但原料较难以获得,且格式反应要求高,也不利于工业化。This route uses R-proline to induce the asymmetric Aldol condensation of meta-substituted benzaldehyde and propionaldehyde, and obtains two chiral centers in one step, and replaces the hydroxyl group with Grignard reaction after sulfonylation, and finally removes the protecting group to obtain the desired product . Although the route is short and two chiral centers can be formed in one step, the raw materials are difficult to obtain, and the Grignard reaction requires high requirements, which is not conducive to industrialization.

路线4(见国际专利文献WO2011/080736A1):Route 4 (see international patent document WO2011/080736A1):

该路线使用间甲氧基苯丙酮与烷基磷酸脂为原料,使用Horner-Wadsworth-Emmons反应,仅用四步反应就合成得到目标产物。虽然该路线合成方法较新颖,路线短,但实施过程要求较苛刻,使用贵金属催化、无水无氧、超低温、柱层析分离等操作,也不可能用于大规模工业化生产。This route uses m-methoxypropiophenone and alkyl phosphate as raw materials, and uses Horner-Wadsworth-Emmons reaction to synthesize the target product in only four steps. Although the synthesis method of this route is relatively novel and the route is short, the implementation process requires more stringent requirements, and it is impossible to use in large-scale industrial production by using noble metal catalysis, anhydrous and oxygen-free, ultra-low temperature, column chromatography separation and other operations.

路线5(见国际专利文献WO2011/080756A1):Route 5 (see international patent document WO2011/080756A1):

该路线使用间甲氧基苯甲醛与氰基乙酸乙酯为起始原料,通过Knoevenagel反应生成2-氰基-3-间甲氧基苯基丙烯酸乙酯,再使用乙基格氏试剂加成、甲基化、脱羧、氰基还原、氨基双甲基化、脱酚甲醚、手性拆分等7步反应得到最终产物。该路线较长,还原氰基使用的硼烷二甲硫醚毒性大且易燃,反应操作繁琐,不宜用于大量生产。This route uses m-methoxybenzaldehyde and ethyl cyanoacetate as starting materials, generates 2-cyano-3-m-methoxyphenyl acrylate ethyl ester through Knoevenagel reaction, and then uses ethyl Grignard reagent addition , methylation, decarboxylation, cyano group reduction, amino dimethylation, dephenol methyl ether, chiral resolution and other 7-step reactions to obtain the final product. This route is long, and the borane dimethyl sulfide used for reducing cyano groups is highly toxic and flammable, and the reaction operation is cumbersome, so it is not suitable for mass production.

路线6(见中国专利文献CN102557851):Route 6 (see Chinese patent document CN102557851):

该路线以间位取代的苯丙酮还原,得到的仲醇用卤素取代,然后直接用甲基丙二酸二乙酯亲核取代,产物水解脱羧得到2-甲基-3-苯基戊酸,再经过成酰胺、还原、保护基脱除及手性拆分得到最终产物。虽然该路线操作简单,原料成本低廉,但合成路线长,生产过程会产生较多废弃物,也不适合工业化生产要求。This route is reduced with meta-substituted propiophenone, and the obtained secondary alcohol is substituted with halogen, and then directly nucleophilicly substituted with diethyl methylmalonate, and the product is hydrolyzed and decarboxylated to obtain 2-methyl-3-phenylpentanoic acid, The final product was obtained through amide formation, reduction, removal of protecting groups and chiral resolution. Although the route is simple to operate and the cost of raw materials is low, the synthesis route is long and the production process will generate more waste, which is not suitable for industrial production requirements.

路线7(见中国专利文献CN102617501A):Route 7 (see Chinese patent document CN102617501A):

or

该路线以肉桂酸或者2-戊烯酸为起始原料,先与手性胺形成酰胺后,再进行手性诱导的不对称Macheal加成,上乙基或间位取代的苯,再在羰基α-位上甲基后,脱掉手性胺基,换成二甲胺,脱掉酚羟基保护后,得到他喷他多。虽然此路线原料便宜易得,但操作繁琐。The route uses cinnamic acid or 2-pentenoic acid as the starting material, first forms an amide with a chiral amine, and then performs chiral-induced asymmetric Macheal addition, adding ethyl or meta-substituted benzene, and then adding carbonyl After the methyl group is attached to the α-position, the chiral amino group is removed and replaced with dimethylamine, and after the protection of the phenolic hydroxyl group is removed, tapentadol is obtained. Although the raw materials of this route are cheap and easy to obtain, the operation is cumbersome.

路线8(见中国专利文献CN102936205):Route 8 (see Chinese patent document CN102936205):

该路线是以1-(二甲氨基)-2-甲基-3-戊酮被还原后,进行羟基卤代,再将所得卤代物与间甲氧基硼试剂、硅试剂或锡试剂在镍催化下进行偶联反应,然后脱甲基得到消旋的他喷他多,最后手性拆分得到光学活性的最终产物。该路线成本很高,尤其锡试剂有较强毒性,且拆分在最后一步进行,产生较多废弃物,存在环保污染问题,因此也不宜工业化应用。This route is after 1-(dimethylamino)-2-methyl-3-pentanone is reduced, carries out hydroxyhalogenation, and then the gained halide is reacted with m-methoxy boron reagent, silicon reagent or tin reagent in nickel A coupling reaction is carried out under catalysis, followed by demethylation to obtain racemized tapentadol, and finally chiral resolution to obtain an optically active final product. The cost of this route is very high, especially the tin reagent is highly toxic, and the splitting is carried out in the last step, which generates more waste and has environmental pollution problems, so it is not suitable for industrial application.

路线9(见美国专利文献US20130150622A1、国际专利文献WO2013090161):Route 9 (see US patent document US20130150622A1, international patent document WO2013090161):

该路线利用肉桂醇丙烯醚的不对称Claisen重排,生成2-甲基-3-苯基-4-戊烯醛,再经过还原胺化得到N,N,2-三甲基-3-苯基-4-戊烯氨,最后加氢还原双键并脱去保护基得到所要产物。虽然该路线设计巧妙,但是路线较长,多步使用了昂贵的催化剂,且反应条件要求严苛,也无法适用于大规模工业生产。This route utilizes the asymmetric Claisen rearrangement of cinnamyl alcohol propylene ether to generate 2-methyl-3-phenyl-4-pentenal, which is then reductively aminated to give N,N,2-trimethyl-3-benzene Base-4-pentenylamine, and finally hydrogenation to reduce the double bond and remove the protecting group to obtain the desired product. Although the route is ingeniously designed, the route is long, expensive catalysts are used in multiple steps, and the reaction conditions are harsh, and it is not suitable for large-scale industrial production.

路线10(见国际专利文献WO2012089177A1和WO2012089181):Route 10 (see international patent documents WO2012089177A1 and WO2012089181):

该路线用肉桂醇丙酸酯为起始原料,在碱的催化下重排生成2-甲基-3-苯基-4-戊烯酸,再经过二甲胺化、还原、脱保护等步骤得到所要产物。该路线需在低温、无水条件下反应,工业应用较困难,且拆分损失较大。This route uses cinnamyl alcohol propionate as the starting material, rearranges under the catalysis of alkali to generate 2-methyl-3-phenyl-4-pentenoic acid, and then undergoes steps such as dimethylamination, reduction, and deprotection The desired product was obtained. This route needs to be reacted under low temperature and anhydrous conditions, and the industrial application is relatively difficult, and the resolution loss is relatively large.

综上所述可见,虽然盐酸他喷他多的合成方法文献报道较多,但均存在不利于工业化生产的各种缺陷问题:有的路线太长,有的使用了昂贵或有毒的化学试剂,有的反应操作繁琐,有的对反应设备要求较高;以致采用现有技术工业制备盐酸他喷他多的成本居高不下,不能满足规模化生产要求。In summary, although there are many synthetic methods of tapentadol hydrochloride reported in the literature, there are various defects that are unfavorable for industrialized production: some routes are too long, some use expensive or toxic chemical reagents, Some reaction operations are cumbersome, and some have higher requirements on reaction equipment; as a result, the cost of industrially preparing tapentadol hydrochloride using the prior art remains high, which cannot meet the requirements of large-scale production.

发明内容Contents of the invention

本发明针对现有技术存在的上述问题和缺陷,旨在提供一种通过反应直接得到所要的手性异构体的合成盐酸他喷他多的方法,以避免因手性拆分而产生大量废弃物,实现提高收率、降低成本、缩短反应路线、简化操作等工业化生产要求。The present invention aims at the above-mentioned problems and defects in the prior art, and aims to provide a method for synthesizing tapentadol hydrochloride that directly obtains the desired chiral isomer through reaction, so as to avoid a large amount of waste due to chiral resolution. material, to achieve industrial production requirements such as increasing yield, reducing cost, shortening reaction route, and simplifying operation.

为实现上述发明目的,本发明采用的技术方案如下:For realizing above-mentioned purpose of the invention, the technical scheme that the present invention adopts is as follows:

一种合成盐酸他喷他多的方法,包括如下反应路线:A method for synthesizing tapentadol hydrochloride, comprising the following reaction scheme:

其中:in:

反应a是使式Ⅳ所示的间位取代的苯丙酮为原料,与多聚甲醛和二甲胺盐酸盐在手性催化剂的催化诱导下反应,得到式Ⅲ所示的(S)-3-二甲氨基-2-甲基-1-间位取代苯基-1-丙酮;Reaction a is to make meta-substituted propiophenone shown in formula IV as raw material, and react with paraformaldehyde and dimethylamine hydrochloride under the catalytic induction of chiral catalyst to obtain (S)-3 shown in formula III -Dimethylamino-2-methyl-1-meta-substituted phenyl-1-propanone;

反应b是使式Ⅲ所示的(S)-3-二甲氨基-2-甲基-1-间位取代苯基-1-丙酮与乙基磷酸酯或乙基三苯基溴化磷或乙基三苯基氯化磷在碱的作用下反应,得到式Ⅱ所示的(S)-N,N,2-三甲基-3-间位取代苯基-3-戊烯氨;Reaction b is to make (S)-3-dimethylamino-2-methyl-1-meta-substituted phenyl-1-acetone shown in formula III with ethyl phosphoric acid ester or ethyl triphenylphosphine bromide or Ethyltriphenylphosphorous chloride is reacted under the action of a base to obtain (S)-N,N,2-trimethyl-3-meta-substituted phenyl-3-pentenylamine shown in formula II;

反应c是使式Ⅱ所示的(S)-N,N,2-三甲基-3-间位取代苯基-3-戊烯氨在过渡金属催化下加氢还原反应,得到式Ⅰ所示的盐酸他喷他多;Reaction c is the hydrogenation reduction reaction of (S)-N,N,2-trimethyl-3-substituted phenyl-3-pentenylamine shown in formula II under transition metal catalysis to obtain the The indicated tapentadol hydrochloride;

式中的R1为卤素、-OH、-OR4、-NO2、-NH2、-NR5R6、-SH、-SR7中的一种。In the formula, R 1 is one of halogen, -OH, -OR 4 , -NO 2 , -NH 2 , -NR 5 R 6 , -SH, -SR 7 .

作为优选方案,所述的R4为烷基、环烷基、亚烷基苯基、亚烷基萘基、四氢吡喃、酰基或硅烷基中的一种;所述的R5和R6分别或同时为H、苄基、苄氧基甲基、2,4-二甲氧基苄基、2,6-二甲氧基苄基、4-甲氧基苄基、邻硝基苄基、4-硝基苄基、2-氯苄基、4-氯苄基、2,4-二氯苄基、2,6-二氯苄基、甲酰基、甲氧基酰基、乙酰基、乙氧基酰基、三氟乙酰基、氯乙酰基、三氯乙酰基、丙酰基、环丙基甲酰基、正丁酰基、异丁酰基、正戊酰基、异戊酰基、正己酰基、异己酰基、正庚酰基、异庚酰基、苯甲酰基、苄氧基酰基、二苯甲酰基、苯磺酰基、对甲基苯磺酰基、叔丁基、烯丙基;所述的R7为苄基、苄氧基甲基、2,4-二甲氧基苄基、2,6-二甲氧基苄基、4-甲氧基苄基、邻硝基苄基、4-硝基苄基、2-氯苄基、4-氯苄基、2,4-二氯苄基、2,6-二氯苄基、2,4,6-三甲氧基苄基、2,4,6-三甲基苄基、二苯甲基、三苯甲基、叔丁基、甲氧基甲基、苄氧基甲基、乙酰基、苯甲酰基、三氟乙酰基中的一种。As a preferred version, the R 4 is one of alkyl, cycloalkyl, alkylene phenyl, alkylene naphthyl, tetrahydropyran, acyl or silyl; the R 5 and R 6 are H, benzyl, benzyloxymethyl, 2,4-dimethoxybenzyl, 2,6-dimethoxybenzyl, 4-methoxybenzyl, o-nitrobenzyl, respectively or simultaneously Base, 4-nitrobenzyl, 2-chlorobenzyl, 4-chlorobenzyl, 2,4-dichlorobenzyl, 2,6-dichlorobenzyl, formyl, methoxyacyl, acetyl, Ethoxyacyl, trifluoroacetyl, chloroacetyl, trichloroacetyl, propionyl, cyclopropylformyl, n-butyryl, isobutyryl, n-valeryl, isovaleryl, n-hexanoyl, isohexanoyl, N-heptanoyl, isoheptanoyl, benzoyl, benzyloxyacyl, dibenzoyl, benzenesulfonyl, p-toluenesulfonyl, tert-butyl, allyl; the R7 is benzyl, benzyl Oxymethyl, 2,4-dimethoxybenzyl, 2,6-dimethoxybenzyl, 4-methoxybenzyl, o-nitrobenzyl, 4-nitrobenzyl, 2- Chlorobenzyl, 4-chlorobenzyl, 2,4-dichlorobenzyl, 2,6-dichlorobenzyl, 2,4,6-trimethoxybenzyl, 2,4,6-trimethylbenzyl One of group, benzhydryl, trityl, tert-butyl, methoxymethyl, benzyloxymethyl, acetyl, benzoyl, trifluoroacetyl.

作为进一步优选方案,所述烷基选自甲基、乙基、正丙基、异丙基、环丙基甲基、烯丙基、炔丙基、正丁基、异丁基、叔丁基、正戊基、异戊基、新戊基、正己基、异己基、正庚基、异庚基中的一种;所述环烷基选自环丙基、环丁基、环戊基、环己基、环庚基中的一种;所述亚烷基苯基选自苄基、苄氧基甲基、2,6-二甲基苄基、4-甲氧基苄基、2,4-二甲氧基苄基、2,6-二甲氧基苄基、邻硝基苄基、4-硝基苄基、2-氯苄基、4-氯苄基、2,4-二氯苄基、2,6-二氯苄基中的一种;所述酰基选自甲酰基、甲氧基酰基、乙酰基、乙氧基酰基、三氟乙酰基、氯乙酰基、三氯乙酰基、丙酰基、环丙基甲酰基、正丁酰基、异丁酰基、正戊酰基、异戊酰基、正己酰基、异己酰基、正庚酰基、异庚酰基、苯甲酰基、苯磺酰基、对甲基苯磺酰基中的一种;所述硅烷基选自三甲基硅基、叔丁基二甲基硅基、叔丁基二苯基硅基或三异丙基硅基中的一种。As a further preferred version, the alkyl group is selected from methyl, ethyl, n-propyl, isopropyl, cyclopropylmethyl, allyl, propargyl, n-butyl, isobutyl, tert-butyl , n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, n-heptyl, isoheptyl; the cycloalkyl is selected from cyclopropyl, cyclobutyl, cyclopentyl, One of cyclohexyl and cycloheptyl; the alkylene phenyl is selected from benzyl, benzyloxymethyl, 2,6-dimethylbenzyl, 4-methoxybenzyl, 2,4 -Dimethoxybenzyl, 2,6-dimethoxybenzyl, o-nitrobenzyl, 4-nitrobenzyl, 2-chlorobenzyl, 4-chlorobenzyl, 2,4-dichlorobenzyl One of benzyl and 2,6-dichlorobenzyl; the acyl group is selected from formyl, methoxyacyl, acetyl, ethoxyacyl, trifluoroacetyl, chloroacetyl, trichloroacetyl , propionyl, cyclopropylformyl, n-butyryl, isobutyryl, n-valeryl, isovaleryl, n-hexanoyl, isohexanoyl, n-heptanoyl, isoheptanoyl, benzoyl, benzenesulfonyl, p-methyl One of phenylsulfonyl groups; the silyl group is selected from one of trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl or triisopropylsilyl.

作为一种优选方案,所述方法包括如下反应路线:As a preferred version, the method includes the following reaction scheme:

其中的:one of them:

R为H、4-甲氧基、2,4-二甲氧基、2,6-二甲氧基、2,6-二甲基、2-硝基、4-硝基、2-氯、4-氯、2,4-二氯、2,6-二氯中的一种;R is H, 4-methoxy, 2,4-dimethoxy, 2,6-dimethoxy, 2,6-dimethyl, 2-nitro, 4-nitro, 2-chloro, One of 4-chloro, 2,4-dichloro, 2,6-dichloro;

反应a、反应b和反应c的内容同上所述。The contents of reaction a, reaction b and reaction c are the same as above.

作为一种优选方案,所述方法包括如下反应路线:As a preferred version, the method includes the following reaction scheme:

其中的:one of them:

反应a和反应b的内容同上所述;The contents of reaction a and reaction b are the same as above;

反应c1是使式Ⅱ所示的(S)-N,N,2-三甲基-3-间位取代苯基-3-戊烯氨与联硼酸频那醇酯先反应生成硼酸酯化合物,再在高硼酸钠的氧化下生成式Ⅰ’所示的酚羟基化合物;Reaction c1 is to first react (S)-N,N,2-trimethyl-3-substituted phenyl-3-pentenylamine shown in formula II with biboronic acid pinacol ester to generate a borate compound , and then generate the phenolic hydroxyl compound shown in formula I' under the oxidation of sodium perborate;

反应c2是使式Ⅰ’所示的酚羟基化合物在过渡金属催化下加氢还原反应,得到式Ⅰ所示的盐酸他喷他多。Reaction c2 is to make the phenolic hydroxyl compound shown in formula I' undergo a hydrogenation reduction reaction under transition metal catalysis to obtain tapentadol hydrochloride shown in formula I.

作为进一步优选方案,反应c1包括如下操作:将式Ⅱ所示卤代物溶于适宜的溶剂中,然后加入联硼酸频那醇酯、催化剂和碱,加热反应;当检测反应结束,再加入相当于原溶剂1/4的水和高硼酸钠,室温搅拌至反应结束;调节反应体系中的pH值至9~10。As a further preferred solution, reaction c1 includes the following operations: dissolving the halogenated compound shown in formula II in a suitable solvent, then adding biboronic acid pinacol ester, catalyst and base, and heating the reaction; when the detection reaction is over, adding the equivalent 1/4 of the original solvent water and sodium perborate, stirred at room temperature until the reaction is completed; adjust the pH value in the reaction system to 9-10.

作为更进一步优选方案,所述适宜的溶剂为四氢呋喃、2-甲基四氢呋喃、甲苯、1,4-二氧六环、DMF、DMSO、甲基叔丁基醚、异丙醚中的一种,以1,4-二氧六环最佳。As a further preferred solution, the suitable solvent is one of tetrahydrofuran, 2-methyltetrahydrofuran, toluene, 1,4-dioxane, DMF, DMSO, methyl tert-butyl ether, isopropyl ether, 1,4-dioxane is the best.

作为更进一步优选方案,所述的催化剂为钯催化剂,可选自Pd[(PPh3)]4、Pd[(PPh3)2]Cl2、Pd(dba)2、Pd2(dba)3、Pd(dppf)Cl2、Pd(dppp)Cl2、Pd[(CH3CN)2]Cl2、Pd[(PCy3)2]Cl2或Pd[P(t-Bu)3]2,以Pd[(PPh3)]4或Pd(dppf)Cl2最佳。As a further preferred solution, the catalyst is a palladium catalyst, which can be selected from Pd[(PPh 3 )] 4 , Pd[(PPh 3 ) 2 ]Cl 2 , Pd(dba) 2 , Pd 2 (dba) 3 , Pd(dppf)Cl 2 , Pd(dppp)Cl 2 , Pd[(CH 3 CN) 2 ]Cl 2 , Pd[(PCy 3 ) 2 ]Cl 2 or Pd[P(t-Bu) 3 ] 2 , with Pd[(PPh 3 )] 4 or Pd(dppf)Cl 2 are the best.

作为更进一步优选方案,所述的碱选自三乙胺、二异丙基乙基胺、碳酸钾、碳酸钠、乙酸钾、乙酸钠、碳酸铯、磷酸钾、磷酸钠中的至少一种,以乙酸钾、乙酸钠最佳。As a further preferred version, the base is selected from at least one of triethylamine, diisopropylethylamine, potassium carbonate, sodium carbonate, potassium acetate, sodium acetate, cesium carbonate, potassium phosphate, sodium phosphate, Potassium acetate and sodium acetate are the best.

作为更进一步优选方案,所述的高硼酸钠选自一水高硼酸钠、三水高硼酸钠或四水高硼酸钠。As a further preferred solution, the sodium perborate is selected from sodium perborate monohydrate, sodium perborate trihydrate or sodium perborate tetrahydrate.

作为一种优选方案,所述方法包括如下反应路线:As a preferred version, the method includes the following reaction scheme:

其中的:one of them:

反应a和反应b的内容同上所述;The contents of reaction a and reaction b are the same as above;

反应c3是使式Ⅱ所示的(S)-N,N,2-三甲基-3-间位取代苯基-3-戊烯氨在过渡金属催化下加氢还原反应,生成式Ⅰ”所示的氨基化合物;Reaction c3 is the hydrogenation reduction reaction of (S)-N,N,2-trimethyl-3-substituted phenyl-3-pentenylamine shown in formula II under transition metal catalysis to generate formula I" the indicated amino compound;

反应c4是使式Ⅰ”所示的氨基化合物在亚硝酸钠存在下先重氮化,然后再水解得到式Ⅰ所示的盐酸他喷他多。Reaction c4 is to make the amino compound shown in formula I" be diazotized in the presence of sodium nitrite, and then hydrolyzed to obtain tapentadol hydrochloride shown in formula I".

作为进一步优选方案,反应a中所述的手性催化剂为手性氨基酸、手性生物碱或其他含手性中心的有机小分子,例如:脯氨酸及其类似物、酒石酸及其衍生物、奎宁及其类似物等。As a further preferred option, the chiral catalyst described in reaction a is a chiral amino acid, a chiral alkaloid or other small organic molecules containing a chiral center, such as: proline and its analogs, tartaric acid and its derivatives, Quinine and its analogues, etc.

作为更进一步优选方案,所述的手性催化剂为L-脯氨酸或L-酒石酸。As a further preferred solution, the chiral catalyst is L-proline or L-tartaric acid.

作为进一步优选方案,反应a所用溶剂为水、甲醇、乙醇、正丙醇、异丙醇、四氢呋喃、2-甲基四氢呋喃、乙腈、甲苯、二氯甲烷、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲亚砜中的至少一种。As a further preferred version, the solvent used in reaction a is water, methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran, 2-methyltetrahydrofuran, acetonitrile, toluene, methylene chloride, N,N-dimethylformamide, At least one of N,N-dimethylacetamide and dimethyl sulfoxide.

作为进一步优选方案,反应b中所述的乙基磷酸酯的结构通式为:式中的R2和R3同时或分别为脂肪烷基、苯基、萘基、苄基、烯丙基中的一种。As a further preferred version, the general structural formula of the ethyl phosphate described in the reaction b is: R2 and R3 in the formula are simultaneously or respectively one of aliphatic alkyl, phenyl, naphthyl, benzyl and allyl.

作为更进一步优选方案,所述的脂肪烷基选自甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、正戊基、异戊基、新戊基、正己基、异己基、正庚基、异庚基中的一种;所述的苄基选自苯基苄基、苄氧基甲基、2,6-二甲基苄基、4-甲氧基苄基、2,4-二甲氧基苄基、2,6-二甲氧基苄基、邻硝基苄基、4-硝基苄基、2-氯苄基、4-氯苄基、2,4-二氯苄基、2,6-二氯苄基中的一种。As a further preferred version, the fatty alkyl group is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, neopentyl one of base, n-hexyl, isohexyl, n-heptyl, and isoheptyl; the benzyl is selected from phenylbenzyl, benzyloxymethyl, 2,6-dimethylbenzyl, 4- Methoxybenzyl, 2,4-dimethoxybenzyl, 2,6-dimethoxybenzyl, o-nitrobenzyl, 4-nitrobenzyl, 2-chlorobenzyl, 4-chlorobenzyl One of benzyl, 2,4-dichlorobenzyl, and 2,6-dichlorobenzyl.

作为进一步优选方案,反应b所用溶剂选自四氢呋喃、2-甲基四氢呋喃、乙醚、甲基叔丁基醚、异丙醚、甲苯、正己烷、正庚烷中的至少一种。As a further preferred solution, the solvent used in reaction b is at least one selected from tetrahydrofuran, 2-methyltetrahydrofuran, diethyl ether, methyl tert-butyl ether, isopropyl ether, toluene, n-hexane, and n-heptane.

作为进一步优选方案,反应b中所述的碱选自甲醇钠、乙醇钠、氢化钠、叔丁醇钠、叔丁醇钾、正丁基锂中的至少一种。As a further preferred solution, the base in reaction b is at least one selected from sodium methoxide, sodium ethoxide, sodium hydride, sodium tert-butoxide, potassium tert-butoxide, and n-butyllithium.

作为进一步优选方案,反应b中的式Ⅲ化合物与乙基磷酸酯或乙基三苯基溴化磷或乙基三苯基氯化磷及碱三者之间的摩尔比为1:(1~2):(1~2),以1:(1.4~1.6):(1.4~1.6)最佳。As a further preferred version, the mol ratio between the compound of formula III in reaction b and ethyl phosphoric acid ester or ethyl triphenyl phosphorus bromide or ethyl triphenyl phosphorus chloride and alkali is 1:(1~ 2):(1~2), 1:(1.4~1.6):(1.4~1.6) is the best.

作为进一步优选方案,反应b的反应温度为0~100℃,以40~70℃最佳。As a further preferred solution, the reaction temperature of reaction b is 0-100°C, most preferably 40-70°C.

作为进一步优选方案,反应c中所述的过渡金属催化剂选自钯、碳载钯、镍、铂、碳载铂、碳载钌、碳载铑中的一种。As a further preferred solution, the transition metal catalyst described in reaction c is selected from one of palladium, palladium on carbon, nickel, platinum, platinum on carbon, ruthenium on carbon, and rhodium on carbon.

作为进一步优选方案,反应c所用的溶剂选自水、甲醇、乙醇、正丙醇、异丙醇、叔丁醇、四氢呋喃、2-甲基四氢呋喃、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺中的至少一种。As a further preferred version, the solvent used in reaction c is selected from water, methanol, ethanol, n-propanol, isopropanol, tert-butanol, tetrahydrofuran, 2-methyltetrahydrofuran, N,N-dimethylformamide, N, At least one of N-dimethylacetamides.

相对于现有技术,本发明通过手性催化的方式,通过反应直接得到所要的手性异构体,避免了因手性拆分而产生的大量废弃物和环保问题,不仅整个路线短,而且操作简单,易于工业化,并且原料利用率高,大大提高了收率,降低了成本,符合工业化生产盐酸他喷他多的要求,具有显著性进步。Compared with the prior art, the present invention directly obtains the desired chiral isomer through reaction through chiral catalysis, avoids a large amount of waste and environmental protection problems caused by chiral resolution, not only the whole route is short, but also The method is simple in operation, easy in industrialization, high in raw material utilization rate, greatly improved in yield, lowered in cost, meets the requirements of industrialized production of tapentadol hydrochloride, and has significant progress.

具体实施方式detailed description

下面结合实施例对本发明做进一步详细、完整地说明。The present invention will be described in further detail and completely below in conjunction with the embodiments.

实施例1:(S)-3-二甲氨基-2-甲基-1-间甲氧基苯基-1-丙酮(式Ⅲ化合物)的合成Example 1: Synthesis of (S)-3-dimethylamino-2-methyl-1-m-methoxyphenyl-1-propanone (compound of formula III)

将164.2g间甲氧基苯丙酮(式Ⅳ化合物)、244.6g二甲胺盐酸盐、90g多聚甲醛及9.9g质量分数为37%的盐酸水溶液溶于200mL乙醇中,再加入34.5g L-脯氨酸,混合反应物在氮气保护下加热至回流,回流反应16小时后,冷却至室温,先减压蒸掉大部分溶剂,残余物加水溶解,再加浓氨水溶液调节pH值至碱性,二氯甲烷萃取3次,合并有机层后,稀氨水洗涤1次,无水Na2SO4干燥,过滤、旋干得淡黄色油状物:(S)-3-二甲氨基-2-甲基-1-间甲氧基苯基-1-丙酮(172.6g,摩尔收率为78%,HPLC纯度为98%,ee=95%);直接用于下一步反应。MS-ESI(m/z):222.1(M+H)+。Dissolve 164.2g of m-methoxypropiophenone (compound of formula IV), 244.6g of dimethylamine hydrochloride, 90g of paraformaldehyde and 9.9g of 37% aqueous hydrochloric acid in 200mL of ethanol, and then add 34.5g of L -Proline, the mixed reactant was heated to reflux under the protection of nitrogen, and after 16 hours of reflux reaction, it was cooled to room temperature, and most of the solvent was evaporated under reduced pressure, and the residue was dissolved in water, and then concentrated ammonia solution was added to adjust the pH value to alkali properties, extracted 3 times with dichloromethane, combined the organic layers, washed 1 time with dilute ammonia water, dried over anhydrous Na 2 SO 4 , filtered, and spin-dried to obtain a light yellow oil: (S)-3-dimethylamino-2- Methyl-1-m-methoxyphenyl-1-propanone (172.6 g, molar yield 78%, HPLC purity 98%, ee=95%); directly used in the next reaction. MS-ESI (m/z): 222.1 (M+H)+.

实施例2:(S)-3-二甲氨基-2-甲基-1-间苄氧基苯基-1-丙酮(式Ⅲ化合物)的合成Embodiment 2: Synthesis of (S)-3-dimethylamino-2-methyl-1-m-benzyloxyphenyl-1-propanone (compound of formula III)

将240.3g间苄氧基苯丙酮(式Ⅳ化合物)、244.6g二甲胺盐酸盐、90g多聚甲醛及9.9g质量分数为37%的盐酸水溶液溶于200mL乙醇中,再加入34.5g L-脯氨酸,混合反应物在氮气保护下加热至回流,回流反应16小时后,冷却至室温,先减压蒸掉大部分溶剂,残余物加水溶解,再加浓氨水溶液调节pH值至碱性,二氯甲烷萃取3次,合并有机层后,稀氨水洗涤1次,无水Na2SO4干燥,过滤、旋干得淡黄色油状物:(S)-3-二甲氨基-2-甲基-1-间苄氧基苯基-1-丙酮(252g,摩尔收率为85%,HPLC纯度为98%,ee=97%);直接用于下一步反应。MS-ESI(m/z):298.2(M+H)+。Dissolve 240.3g of m-benzyloxypropiophenone (compound of formula IV), 244.6g of dimethylamine hydrochloride, 90g of paraformaldehyde and 9.9g of 37% hydrochloric acid aqueous solution in 200mL of ethanol, and then add 34.5g of L -Proline, the mixed reactant was heated to reflux under the protection of nitrogen, and after 16 hours of reflux reaction, it was cooled to room temperature, and most of the solvent was evaporated under reduced pressure, and the residue was dissolved in water, and then concentrated ammonia solution was added to adjust the pH value to alkali properties, extracted 3 times with dichloromethane, combined the organic layers, washed 1 time with dilute ammonia water, dried over anhydrous Na 2 SO 4 , filtered, and spin-dried to obtain a light yellow oil: (S)-3-dimethylamino-2- Methyl-1-m-benzyloxyphenyl-1-propanone (252 g, molar yield 85%, HPLC purity 98%, ee=97%); directly used in the next reaction. MS-ESI (m/z): 298.2 (M+H)+.

实施例3:(S)-3-二甲氨基-2-甲基-1-间溴苯基-1-丙酮(式Ⅲ化合物)的合成Example 3: Synthesis of (S)-3-dimethylamino-2-methyl-1-m-bromophenyl-1-propanone (compound of formula III)

将213.1g间溴苯丙酮(式Ⅳ化合物)、244.6g二甲胺盐酸盐、90g多聚甲醛及9.9g质量分数为37%的盐酸水溶液溶于200mL乙醇中,再加入34.5g L-脯氨酸;混合反应物在氮气保护下加热至回流,回流反应16小时后,冷却至室温,先减压蒸掉大部分溶剂,残余物加水溶解,再加浓氨水溶液调节pH值至碱性,二氯甲烷萃取3次,合并有机层后,稀氨水洗涤1次,无水Na2SO4干燥,过滤、旋干得淡黄色油状物:(S)-3-二甲氨基-2-甲基-1-间溴苯基-1-丙酮(229.7g,摩尔收率为85%,HPLC纯度为95%,ee=96%);直接用于下一步反应。MS-ESI(m/z):270.0,272.0(M+H)+。Dissolve 213.1g of m-bromopropiophenone (compound of formula IV), 244.6g of dimethylamine hydrochloride, 90g of paraformaldehyde and 9.9g of 37% aqueous hydrochloric acid in 200mL of ethanol, and then add 34.5g of L-proline Acid; the mixed reactant was heated to reflux under the protection of nitrogen, and after 16 hours of reflux reaction, it was cooled to room temperature, and most of the solvent was evaporated under reduced pressure first, and the residue was dissolved in water, and then concentrated ammonia solution was added to adjust the pH value to alkaline, Dichloromethane extracted 3 times, combined the organic layers, washed 1 time with dilute ammonia water, dried over anhydrous Na 2 SO 4 , filtered, and spin-dried to obtain a light yellow oil: (S)-3-dimethylamino-2-methyl - 1-m-bromophenyl-1-propanone (229.7g, molar yield 85%, HPLC purity 95%, ee=96%); directly used in the next reaction. MS-ESI (m/z): 270.0, 272.0 (M+H)+.

实施例4:(S)-3-二甲氨基-2-甲基-1-间硝基苯基-1-丙酮(式Ⅲ化合物)的合成Example 4: Synthesis of (S)-3-dimethylamino-2-methyl-1-m-nitrophenyl-1-propanone (compound of formula III)

将179.17g间硝基苯丙酮(式Ⅳ化合物)、244.6g二甲胺盐酸盐、90g多聚甲醛及9.9g质量分数为37%的盐酸水溶液溶于乙醇200mL中,再加入34.5g L-脯氨酸;混合反应物在氮气保护下加热至回流,回流反应16小时后,冷却至室温,先减压蒸掉大部分溶剂,残余物加水溶解,再加浓氨水溶液调节pH值至碱性,二氯甲烷萃取3次,合并有机层后,稀氨水洗涤1次,无水Na2SO4干燥,过滤、旋干得淡黄色油状物:(S)-3-二甲氨基-2-甲基-1-间硝基苯基-1-丙酮(160.6g,摩尔收率为68%,HPLC纯度为93%,ee=97%);直接用于下一步反应。MS-ESI(m/z):237.2(M+H)+。Dissolve 179.17g of m-nitropropiophenone (compound of formula IV), 244.6g of dimethylamine hydrochloride, 90g of paraformaldehyde and 9.9g of 37% hydrochloric acid aqueous solution in 200mL of ethanol, and then add 34.5g of L- Proline; the mixed reactant was heated to reflux under the protection of nitrogen, and after 16 hours of reflux reaction, it was cooled to room temperature, and most of the solvent was evaporated under reduced pressure, and the residue was dissolved in water, and then concentrated ammonia solution was added to adjust the pH value to alkaline , extracted 3 times with dichloromethane, combined the organic layers, washed once with dilute ammonia water, dried over anhydrous Na 2 SO 4 , filtered, and spin-dried to obtain a pale yellow oil: (S)-3-dimethylamino-2-methanol Base-1-m-nitrophenyl-1-propanone (160.6g, molar yield 68%, HPLC purity 93%, ee=97%); directly used in the next reaction. MS-ESI (m/z): 237.2 (M+H)+.

实施例5:(S)-3-二甲氨基-2-甲基-1-[3-(4-甲氧基苄基)苯基]-1-丙酮(式Ⅲ化合物)的合成Example 5: Synthesis of (S)-3-dimethylamino-2-methyl-1-[3-(4-methoxybenzyl)phenyl]-1-propanone (compound of formula III)

将179.17g3-(4-甲氧基苄氧基)苯丙酮(式Ⅳ化合物)、244.6g二甲胺盐酸盐、90g多聚甲醛及9.9g质量分数为37%的盐酸水溶液溶于200mL乙醇中,再加入34.5g L-脯氨酸;混合反应物在氮气保护下加热至回流,回流反应16小时后,冷却至室温,先减压蒸掉大部分溶剂,残余物加水溶解,再加浓氨水溶液调节pH值至碱性,二氯甲烷萃取3次,合并有机层后,稀氨水洗涤1次,无水Na2SO4干燥,过滤、旋干得淡黄色油状物:(S)-3-二甲氨基-2-甲基-1-[3-(4-甲氧基苄氧基)苯基]-1-丙酮(288.1g,摩尔收率为88%,HPLC纯度为99%,ee=99%);直接用于下一步反应。MS-ESI(m/z):328.2(M+H)+。Dissolve 179.17g of 3-(4-methoxybenzyloxy)propiophenone (compound of formula IV), 244.6g of dimethylamine hydrochloride, 90g of paraformaldehyde and 9.9g of 37% hydrochloric acid aqueous solution in 200mL of ethanol 34.5g of L-proline was added; the mixed reactant was heated to reflux under the protection of nitrogen, and after 16 hours of reflux reaction, it was cooled to room temperature, most of the solvent was distilled off under reduced pressure, the residue was dissolved in water, and concentrated Ammonia solution was used to adjust the pH value to alkaline, dichloromethane extracted 3 times, combined organic layers, washed 1 time with dilute ammonia water, dried over anhydrous Na 2 SO 4 , filtered, and spin-dried to obtain a light yellow oil: (S)-3 -Dimethylamino-2-methyl-1-[3-(4-methoxybenzyloxy)phenyl]-1-propanone (288.1 g, 88% molar yield, 99% purity by HPLC, ee =99%); directly used in the next reaction. MS-ESI (m/z): 328.2 (M+H)+.

实施例6:(R)-3-(3-苄氧基苯基)-N,N,2-三甲基戊-3-烯-1-胺(式Ⅱ化合物)的合成Example 6: Synthesis of (R)-3-(3-benzyloxyphenyl)-N,N,2-trimethylpent-3-en-1-amine (compound of formula II)

室温条件下,将278.4g乙基三苯基溴化膦悬浮于500mL甲苯中,搅拌下加入72.1g叔丁醇钠,继续搅拌1小时,反应液呈橙红色,冰浴冷却至20℃以下,慢慢滴加式Ⅲ化合物:(S)-3-二甲氨基-2-甲基-1-间苄氧基苯基-1-丙酮(148.6g,0.5mol)的甲苯溶液(300mL),滴加完毕后,升温至60℃反应3小时,慢慢降至室温;反应液用水洗涤两次,每次均200mL,再用200mL饱和食盐水洗涤,干燥,过滤;向过滤得到的溶液中加入HCl的乙酸乙酯溶液,有白色固体析出,搅拌析晶30min后,过滤,固体用50mL乙酸乙酯洗涤,真空干燥,得到:(R)-3-(3-苄氧基苯基)-N,N,2-三甲基戊-3-烯-1-胺盐酸盐(148.7g,摩尔收率为86%,HPLC纯度为99%);直接用于下一步反应。MS-ESI(m/z):310.2(M+H)+。At room temperature, suspend 278.4 g of ethyltriphenylphosphine bromide in 500 mL of toluene, add 72.1 g of sodium tert-butoxide under stirring, and continue stirring for 1 hour. Slowly add the compound of formula Ⅲ: (S)-3-dimethylamino-2-methyl-1-m-benzyloxyphenyl-1-propanone (148.6g, 0.5mol) in toluene solution (300mL), drop After the addition, the temperature was raised to 60°C for 3 hours, and then slowly lowered to room temperature; the reaction solution was washed twice with water, 200 mL each time, and then washed with 200 mL saturated saline, dried, and filtered; HCl was added to the filtered solution A white solid was precipitated, stirred and crystallized for 30 min, filtered, the solid was washed with 50 mL of ethyl acetate, and dried in vacuo to obtain: (R)-3-(3-benzyloxyphenyl)-N, N,2-trimethylpent-3-en-1-amine hydrochloride (148.7 g, molar yield 86%, HPLC purity 99%); directly used in the next reaction. MS-ESI (m/z): 310.2 (M+H)+.

实施例7:(R)-3-间溴苯基-N,N,2-三甲基戊-3-烯-1-胺(式Ⅱ化合物)的合成Example 7: Synthesis of (R)-3-m-bromophenyl-N,N,2-trimethylpent-3-en-1-amine (compound of formula II)

室温条件下,将278.4g乙基三苯基溴化膦悬浮于500mL甲苯中,搅拌下加入72.1g叔丁醇钠继续搅拌1小时,反应液呈橙红色,冰浴冷却至20℃以下,慢慢滴加式Ⅲ化合物:(S)-3-二甲氨基-2-甲基-1-间溴苯基-1-丙酮(135.1g,0.5mol)的甲苯溶液(300mL),滴加完毕后,升温至60℃反应3小时,慢慢降至室温;反应液用水洗涤两次,每次均用200mL,再用200mL饱和食盐水洗涤,干燥,过滤;向过滤得到的溶液中加入HCl的乙酸乙酯溶液,有白色固体析出,搅拌析晶30min后,过滤,固体用50mL乙酸乙酯洗涤,真空干燥,得到:(R)-3-间溴苯基-N,N,2-三甲基戊-3-烯-1-胺盐酸盐(114.3g,摩尔收率为81%,HPLC纯度为98%);直接用于下一步反应。MS-ESI(m/z):282.0,284.0(M+H)+。At room temperature, suspend 278.4g of ethyltriphenylphosphine bromide in 500mL of toluene, add 72.1g of sodium tert-butoxide under stirring and continue to stir for 1 hour, the reaction solution is orange-red, cooled to below 20°C in an ice bath, slowly Slowly add the compound of formula Ⅲ: (S)-3-dimethylamino-2-methyl-1-m-bromophenyl-1-propanone (135.1g, 0.5mol) in toluene solution (300mL), after the dropwise addition , heated to 60°C for 3 hours, then slowly lowered to room temperature; the reaction solution was washed twice with water, each time with 200mL, and then washed with 200mL saturated saline, dried, and filtered; to the filtered solution was added HCl acetic acid Ethyl solution, a white solid precipitated, stirred and crystallized for 30min, filtered, the solid was washed with 50mL ethyl acetate, and dried in vacuo to obtain: (R)-3-m-bromophenyl-N,N,2-trimethyl Pent-3-en-1-amine hydrochloride (114.3 g, molar yield 81%, HPLC purity 98%); directly used in the next reaction. MS-ESI (m/z): 282.0, 284.0 (M+H)+.

实施例8:(R)-3-间硝基苯基-N,N,2-三甲基戊-3-烯-1-胺(式Ⅱ化合物)的合成Example 8: Synthesis of (R)-3-m-nitrophenyl-N,N,2-trimethylpent-3-en-1-amine (compound of formula II)

室温条件下,将278.4g乙基三苯基溴化膦悬浮于500mL甲苯中,搅拌下加入72.1g叔丁醇钠继续搅拌1小时,反应液呈橙红色,冰浴冷却至20℃以下,慢慢滴加式Ⅲ化合物:(S)-3-二甲氨基-2-甲基-1-间硝基苯基-1-丙酮(118.1g,0.5mol)的甲苯溶液(300mL),滴加完毕后,升温至60℃反应3小时,慢慢降至室温;反应液用水洗涤两次,每次均用200mL,再用200mL饱和食盐水洗涤,干燥,过滤;向过滤得到的溶液中加入HCl的乙酸乙酯溶液,有白色固体析出,搅拌析晶30min后,过滤,固体用50mL乙酸乙酯洗涤,真空干燥,得到:(R)-3-间硝基苯基-N,N,2-三甲基戊-3-烯-1-胺盐酸盐(95.5g,摩尔收率为77%,HPLC纯度为93%);直接用于下一步反应。MS-ESI(m/z):249.1(M+H)+。At room temperature, suspend 278.4g of ethyltriphenylphosphine bromide in 500mL of toluene, add 72.1g of sodium tert-butoxide under stirring and continue to stir for 1 hour, the reaction solution is orange-red, cooled to below 20°C in an ice bath, slowly Slowly add the compound of formula Ⅲ: (S)-3-dimethylamino-2-methyl-1-m-nitrophenyl-1-propanone (118.1g, 0.5mol) in toluene solution (300mL), the dropwise addition is complete Afterwards, the temperature was raised to 60°C for 3 hours, and then slowly lowered to room temperature; the reaction solution was washed twice with water, each time with 200 mL, and then washed with 200 mL of saturated saline, dried, and filtered; added HCl to the filtered solution Ethyl acetate solution, a white solid precipitated, stirred and crystallized for 30min, filtered, the solid was washed with 50mL ethyl acetate, and dried in vacuo to obtain: (R)-3-m-nitrophenyl-N,N,2-tri Methylpent-3-en-1-amine hydrochloride (95.5 g, molar yield 77%, HPLC purity 93%); used directly in the next reaction. MS-ESI (m/z): 249.1 (M+H)+.

实施例9:(R)-3-[3-(4-甲氧基苄氧基)苯基]-N,N,2-三甲基戊-3-烯-1-胺(式Ⅱ化合物)的合成Example 9: (R)-3-[3-(4-methoxybenzyloxy)phenyl]-N,N,2-trimethylpent-3-en-1-amine (compound of formula II) Synthesis

室温条件下,将278.4g乙基三苯基溴化膦悬浮于500mL甲苯中,搅拌下加入72.1g叔丁醇钠继续搅拌1小时,反应液呈橙红色,冰浴冷却至20℃以下,慢慢滴加式Ⅲ化合物:(S)-3-二甲氨基-2-甲基-1-[3-(4-甲氧基苄氧基)苯基]-1-丙酮(163.7g,0.5mol)的甲苯溶液(300mL),滴加完毕后,升温至60℃反应3小时,慢慢降至室温;反应液用水洗涤两次,每次均用200mL,再用200mL饱和食盐水洗涤,干燥,过滤;向过滤得到的溶液中加入HCl的乙酸乙酯溶液,有白色固体析出,搅拌析晶30min后,过滤,固体用50mL乙酸乙酯洗涤,真空干燥,得到:(R)-3-[3-(4-甲氧基苄氧基)苯基]-N,N,2-三甲基戊-3-烯-1-胺盐酸盐(170.7g,摩尔收率为91%,HPLC纯度为99%);直接用于下一步反应。MS-ESI(m/z):340.2(M+H)+。At room temperature, suspend 278.4g of ethyltriphenylphosphine bromide in 500mL of toluene, add 72.1g of sodium tert-butoxide under stirring and continue to stir for 1 hour, the reaction solution is orange-red, cooled to below 20°C in an ice bath, slowly Slowly add the compound of formula III: (S)-3-dimethylamino-2-methyl-1-[3-(4-methoxybenzyloxy)phenyl]-1-propanone (163.7g, 0.5mol ) toluene solution (300mL), after the dropwise addition was completed, the temperature was raised to 60°C for 3 hours, and then slowly lowered to room temperature; Filtration; HCl ethyl acetate solution was added to the solution obtained by filtration, a white solid was precipitated, stirred and crystallized for 30min, filtered, the solid was washed with 50mL ethyl acetate, and dried in vacuo to obtain: (R)-3-[3 -(4-methoxybenzyloxy)phenyl]-N,N,2-trimethylpent-3-en-1-amine hydrochloride (170.7g, molar yield is 91%, HPLC purity is 99%); directly used in the next reaction. MS-ESI (m/z): 340.2 (M+H)+.

实施例10:盐酸他喷他多(式Ⅰ化合物)的合成Embodiment 10: Synthesis of tapentadol hydrochloride (compound of formula I)

将6.9g式Ⅱ化合物:(R)-3-(3-苄氧基苯基)-N,N,2-三甲基戊-3-烯-1-胺溶于20mL甲醇中,加入350mg钯含量为10%的Pd/C,氢气置换3次后,置于室温下搅拌过夜;用硅藻土过滤,除去Pd/C固体,用5mL甲醇洗涤,滤液减压蒸干,得类白色固体5.1g;此固体用乙酸乙酯重结晶,即得白色固体产物盐酸他喷他多(4.2g,摩尔收率为82%,ee=100%);MS-ESI(m/z):222.1(M+H)+。Dissolve 6.9g of the compound of formula II: (R)-3-(3-benzyloxyphenyl)-N,N,2-trimethylpent-3-en-1-amine in 20mL of methanol, add 350mg of palladium Pd/C with a content of 10% was replaced by hydrogen for 3 times, and then stirred overnight at room temperature; filtered with diatomaceous earth to remove the Pd/C solid, washed with 5 mL of methanol, and the filtrate was evaporated to dryness under reduced pressure to obtain off-white solid 5.1 g; this solid was recrystallized with ethyl acetate to obtain the white solid product tapentadol hydrochloride (4.2g, molar yield was 82%, ee=100%); MS-ESI (m/z): 222.1 (M +H)+.

实施例11:盐酸他喷他多(式Ⅰ化合物)的合成Example 11: Synthesis of tapentadol hydrochloride (compound of formula I)

将7.5g式Ⅱ化合物:(R)-3-[3-(4-甲氧基苄氧基)苯基]-N,N,2-三甲基戊-3-烯-1-胺溶于20mL甲醇中,加入350mg钯含量为10%的Pd/C,氢气置换3次后,置于室温下搅拌过夜;用硅藻土过滤,除去Pd/C固体,用5mL甲醇洗涤,滤液减压蒸干,得类白色固体5.0g;此固体用乙酸乙酯重结晶,即得白色固体产物盐酸他喷他多(4.1g,摩尔收率为80%,ee=100%);MS-ESI(m/z):222.1(M+H)+。7.5g of formula II compound: (R)-3-[3-(4-methoxybenzyloxy)phenyl]-N,N,2-trimethylpent-3-en-1-amine was dissolved in Add 350 mg of Pd/C with a palladium content of 10% to 20 mL of methanol, replace with hydrogen three times, and stir overnight at room temperature; filter with diatomaceous earth to remove the Pd/C solid, wash with 5 mL of methanol, and evaporate the filtrate under reduced pressure dry to obtain off-white solid 5.0g; this solid was recrystallized with ethyl acetate to obtain the white solid product tapentadol hydrochloride (4.1g, molar yield was 80%, ee=100%); MS-ESI (m /z): 222.1 (M+H)+.

实施例12:(R)-3-间羟基苯基-N,N,2-三甲基戊-3-烯-1-胺的合成(式Ⅰ’化合物)的合成Example 12: Synthesis of (R)-3-m-hydroxyphenyl-N,N,2-trimethylpent-3-en-1-amine (formula Ⅰ' compound)

将式Ⅱ化合物:(R)-3-间溴苯基-N,N,2-三甲基戊-3-烯-1-胺(5.6g,20mmol)、联硼酸频那醇酯(5.6g,22mmol)、Pd(PPh3)4(1.16g,1mmol)、无水醋酸钾(0.39g,40mmol)溶于1,4-二氧六环(20mL)中,氮气保护下升温至80℃反应过夜,冷却至室温;加入水(5mL)、NaBO3·3H2O(6.8g,50mmol),室温下搅拌8小时;过滤除去不溶物,滤液加水(100mL),加NaOH水溶液调节pH值至9-10,乙酸乙酯萃取(30mL*3),合并有机层,干燥,过滤;有机层滴入HCl乙酸乙酯溶液,有白色固体析出,过滤,得到:(R)-3-间羟基苯基-N,N,2-三甲基戊-3-烯-1-胺盐酸盐(3.33g,摩尔收率为65%,HPLC纯度为92%);MS-ESI(m/z):220.1(M+H)+。The compound of formula Ⅱ: (R)-3-m-bromophenyl-N,N,2-trimethylpent-3-en-1-amine (5.6g, 20mmol), biboronic acid pinacol ester (5.6g , 22mmol), Pd(PPh 3 ) 4 (1.16g, 1mmol), anhydrous potassium acetate (0.39g, 40mmol) were dissolved in 1,4-dioxane (20mL), heated to 80°C under the protection of nitrogen to react Overnight, cool to room temperature; add water (5mL), NaBO 3 3H 2 O (6.8g, 50mmol), stir at room temperature for 8 hours; filter to remove insoluble matter, add water (100mL) to the filtrate, add NaOH aqueous solution to adjust the pH value to 9 -10, extracted with ethyl acetate (30mL*3), combined the organic layers, dried, and filtered; the organic layer was dropped into HCl ethyl acetate solution, a white solid precipitated, filtered to obtain: (R)-3-m-hydroxyphenyl -N,N,2-trimethylpent-3-en-1-amine hydrochloride (3.33g, molar yield 65%, HPLC purity 92%); MS-ESI (m/z): 220.1 (M+H)+.

实施例13:盐酸他喷他多(式Ⅰ化合物)的合成Example 13: Synthesis of tapentadol hydrochloride (compound of formula I)

将3.33g式Ⅰ’化合物:(R)-3-间羟基苯基-N,N,2-三甲基戊-3-烯-1-胺盐酸盐溶于15mL甲醇中,加入150mg钯含量为10%Pd/C,氢气置换3次后,置于室温下搅拌过夜;用硅藻土过滤,除去Pd/C固体,用5mL甲醇洗涤,滤液减压蒸干,得类白色固体3.20g;此固体用乙酸乙酯重结晶,即得白色固体产物盐酸他喷他多(2.70g,摩尔收率为81%,ee=100%);MS-ESI(m/z):222.1(M+H)+。Dissolve 3.33g of the compound of formula Ⅰ': (R)-3-m-hydroxyphenyl-N,N,2-trimethylpent-3-en-1-amine hydrochloride in 15mL of methanol, add 150mg of palladium It was 10% Pd/C, replaced by hydrogen 3 times, and stirred at room temperature overnight; filtered through diatomaceous earth to remove the Pd/C solid, washed with 5 mL of methanol, and the filtrate was evaporated to dryness under reduced pressure to obtain 3.20 g of off-white solid; This solid was recrystallized with ethyl acetate to obtain the white solid product tapentadol hydrochloride (2.70g, molar yield was 81%, ee=100%); MS-ESI (m/z): 222.1 (M+H )+.

实施例14:(1R,2R)-3-(3-二甲基氨基-1-乙基-2-甲基丙基)苯胺盐酸盐(式Ⅰ”化合物)的合成Example 14: Synthesis of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)aniline hydrochloride (compound of formula Ⅰ)

将5.70g式Ⅱ化合物:(R)-3-间硝基苯基-N,N,2-三甲基戊-3-烯-1-胺溶于20mL甲醇中,加入350mg钯含量为10%的Pd/C,氢气置换3次后,置于室温下搅拌过夜;用硅藻土过滤,除去Pd/C固体,用5mL甲醇洗涤,滤液减压蒸干,得类白色固体4.72g;此固体用乙酸乙酯重结晶,得白色固体产物:(1R,2R)-3-(3-二甲基氨基-1-乙基-2-甲基丙基)苯胺盐酸盐(3.78g,摩尔收率为73.6%,ee=100%);MS-ESI(m/z):221.2(M+H)+。Dissolve 5.70g of the compound of formula II: (R)-3-m-nitrophenyl-N,N,2-trimethylpent-3-en-1-amine in 20mL of methanol, add 350mg of palladium to make it 10% Pd/C, hydrogen replacement 3 times, placed at room temperature and stirred overnight; filtered with diatomaceous earth, removed Pd/C solid, washed with 5mL of methanol, and the filtrate was evaporated to dryness under reduced pressure to obtain 4.72g of off-white solid; Recrystallization with ethyl acetate gave a white solid product: (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)aniline hydrochloride (3.78g, molar yield The rate was 73.6%, ee=100%); MS-ESI (m/z): 221.2 (M+H)+.

实施例15:盐酸他喷他多(式Ⅰ化合物)的合成Example 15: Synthesis of tapentadol hydrochloride (compound of formula I)

将20mL质量分数为30-35%的硫酸水溶液加入100mL烧瓶中,冰水浴冷却至0~5℃,然后加入3.78g式Ⅰ”化合物:(1R,2R)-3-(3-二甲基氨基-1-乙基-2-甲基丙基)苯胺盐酸盐,再将5mL0.304g/mL的NaNO2水溶液慢慢滴入;滴毕保温搅拌1小时后,得到重氮盐反应液;在另一个圆底烧瓶中加入20mL质量分数为10~15%的硫酸水溶液,加热到110℃,将前述重氮盐反应液慢慢加入,控制泡沫不要溢出,加入完毕,在100℃保温反应15min,然后冷却至室温;加入NaOH溶液调节pH值至10~11,乙酸乙酯萃取3次,每次用30mL;收集有机层进行干燥后,过滤,加入HCl的乙酸乙酯溶液,产生大量白色固体;过滤,即得白色固体产物盐酸他喷他多(2.85g,摩尔收率为75%,ee=100%);MS-ESI(m/z):222.1(M+H)+。Add 20mL of sulfuric acid aqueous solution with a mass fraction of 30-35% into a 100mL flask, cool in an ice-water bath to 0-5°C, and then add 3.78g of the compound of formula I": (1R,2R)-3-(3-Dimethylamino -1-ethyl- 2 -methylpropyl) aniline hydrochloride, then 5mL of 0.304g/mL NaNO2 aqueous solution is slowly dripped in; After dripping and stirring for 1 hour, the diazonium salt reaction solution is obtained; Add 20mL of sulfuric acid aqueous solution with a mass fraction of 10-15% to another round-bottomed flask, heat it to 110°C, add the aforementioned diazonium salt reaction solution slowly, and control the foam not to overflow. Then cool to room temperature; add NaOH solution to adjust the pH value to 10-11, extract with ethyl acetate three times, each time with 30 mL; collect the organic layer to dry, filter, add HCl in ethyl acetate solution, a large amount of white solid is produced; After filtration, the white solid product tapentadol hydrochloride (2.85 g, molar yield 75%, ee=100%) was obtained; MS-ESI (m/z): 222.1 (M+H)+.

最后有必要在此说明的是:以上实施例只用于对本发明的技术方案作进一步详细地说明,不能理解为对本发明保护范围的限制,本领域的技术人员根据本发明的上述内容作出的一些非本质的改进和调整均属于本发明的保护范围。Finally, it is necessary to explain here that: the above examples are only used to further describe the technical solutions of the present invention in detail, and cannot be interpreted as limiting the protection scope of the present invention. Non-essential improvements and adjustments all belong to the protection scope of the present invention.

Claims (11)

1. a kind of method of synthetic hydrochloric acid tapentadol hydrochloride, including following reaction scheme:
Wherein:
Step b is to make (S) -3- dimethylaminos -2- methyl isophthalic acids-m-phenylcnc -1- acetone and the ethyl phosphonic acid shown in formula III Ester or Ethyltriphenylphosphonium brimide or ethyltriphenyl phosphonium chloride phosphorus react in the presence of alkali, obtain (S)-N, the N shown in formula II, 2- trimethyl -3- m-phenylcnc -3- amylene ammonia;
Step c is to make (S)-N, N, the 2- trimethyl -3- m-phenylcnc -3- amylene ammonia shown in formula II transition metal-catalyzed Lower hydrogenation reduction, obtains the tapentadol hydrochloride shown in formula I;It is characterized in that:
Step a is the propiophenone and paraformaldehyde and dimethylamine hydrochloride for replacing the meta shown in formula IV in L-PROLINE or L- The lower reaction of catalysis induction of tartaric acid, directly obtains (the S) -3- dimethylaminos -2- methyl isophthalic acids-meta substituted benzene shown in formula III Base -1- acetone;
R in formula1It is halogen ,-OH ,-OR4、-NH2In one kind, described R4Selected from methyl, ethyl, n-propyl, isopropyl, ring Hydroxypropyl methyl, pi-allyl, propargyl, normal-butyl, isobutyl group, the tert-butyl group, n-pentyl, isopentyl, neopentyl, n-hexyl, dissident Base, n-heptyl, different heptyl, cyclopropyl, cyclobutyl, cyclopenta, cyclohexyl, suberyl, benzyl, benzyloxymethyl, 2,6- diformazans Base benzyl, 4- methoxy-benzyls, 2,4- dimethoxy-benzyls, 2,6- dimethoxy-benzyls, adjacent nitro benzyl, 4- nitrobenzyls, 2- chlorobenzyls, 4- chlorobenzyls, 2,4- dichloro benzyls, 2,6- dichloro benzyls, formoxyl, methoxyl group acyl group, acetyl group, ethyoxyl acyl Base, trifluoroacetyl group, chloracetyl, tribromo-acetyl base, propiono, cyclopropyl formoxyl, positive bytyry, isobutyryl, positive penta Acyl group, isovaleryl, positive caproyl, isocaproyl, positive heptanoyl group, different heptanoyl group, benzoyl, benzenesulfonyl, to methylbenzene One kind in sulfonyl, trimethyl silicon substrate, t-Butyldimethylsilyl, tert-butyl diphenyl silicon substrate or triisopropylsilyl.
2. the method for claim 1, it is characterised in that methods described includes following reaction scheme:
It is therein:
R is H, 4- methoxyl group, 2,4- dimethoxys, 2,6- dimethoxys, 2,6- dimethyl, 2- nitros, 4- nitros, 2- chlorine, 4- One kind in chlorine, 2,4- dichloros, 2,6- dichloros;The content of step a, step b and step c is with described in claim 1.
3. the method for claim 1, it is characterised in that methods described includes following reaction scheme:
It is therein:
The content of step a and step b is with described in claim 1;
Step c1 be make (S)-N, N, 2- trimethyls -3- m-phenylcncs -3- amylenes ammonia shown in formula II and connection boric acid frequency that Alcohol ester first reacts generation boric acid ester compound, then the phenolic hydroxyl-compounds under the oxidation of sodium perborate shown in production I ';
Step c2 is to make the phenolic hydroxyl-compounds shown in formula I ' in transition metal-catalyzed lower hydrogenation reduction, is obtained shown in formula I Tapentadol hydrochloride.
4. method as claimed in claim 3, it is characterised in that step c1 includes following operation:Halides shown in formula II are molten In suitable solvent, connection boric acid pinacol ester, catalyst and alkali, heating response are subsequently adding;When detection reaction terminates, then add Enter the water and sodium perborate equivalent to former solvent 1/4, be stirred at room temperature to reaction and terminate;PH value in regulation reaction system to 9~ 10。
5. method as claimed in claim 4, it is characterised in that:The suitable solvent is tetrahydrofuran, 2- methyl tetrahydrochysene furans Mutter, the one kind in toluene, 1,4- dioxane, DMF, DMSO, methyl tertiary butyl ether(MTBE), isopropyl ether;Described catalyst is urged for palladium Agent;Described alkali is selected from triethylamine, diisopropyl ethyl amine, potassium carbonate, sodium carbonate, potassium acetate, sodium acetate, cesium carbonate, phosphorus At least one in sour potassium, sodium phosphate;Described sodium perborate is selected from a water sodium perborate, three water sodium perborate or four water boron high Sour sodium.
6. the method for claim 1, it is characterised in that methods described includes following reaction scheme:
It is therein:
The content of step a and step b is with described in claim 1;
Step c3 is (S)-N, N, the 2- trimethyl -3- m-phenylcnc -3- amylene ammonia shown in formula II is urged in transition metal Amino-compound shown in hydrogenation reduction under changing, production I ";
Step c4 is to make formula I " shown in amino-compound in the presence of natrium nitrosum first diazotising, the formula of obtaining I is then hydrolyzed again Shown tapentadol hydrochloride.
7. the method for claim 1, it is characterised in that:Step a solvent for use is water, methyl alcohol, ethanol, normal propyl alcohol, different Propyl alcohol, tetrahydrofuran, 2- methyltetrahydrofurans, acetonitrile, toluene, dichloromethane, N,N-dimethylformamide, N, N- dimethyl second At least one in acid amides, dimethyl sulfoxide.
8. the method for claim 1, it is characterised in that:The general structure of the ethyl phosphonic acid ester described in step b is:R2 and R3 in formula are selected from methyl, ethyl, n-propyl, isopropyl, normal-butyl, isobutyl group, uncle at the same time or separately Butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohesyl, n-heptyl, different heptyl, phenylbenzyl, benzyloxymethyl, 2, 6- dimethyl benzyls, 2,4- dimethyl benzyls, 4- methoxy-benzyls, adjacent nitro benzyl, 4- nitrobenzyls, 2- chlorobenzyls, 4- chlorine One kind in benzyl, 2,4- dichloro benzyls, 2,6- dichloro benzyls.
9. the method for claim 1, it is characterised in that:Step b solvent for use is selected from tetrahydrofuran, 2- methyl tetrahydrochysene furans Mutter, at least one in ether, methyl tertiary butyl ether(MTBE), isopropyl ether, toluene, n-hexane, normal heptane;Alkali choosing described in step b At least one from sodium methoxide, caustic alcohol, sodium hydride, sodium tert-butoxide, potassium tert-butoxide, n-BuLi.
10. the method for claim 1, it is characterised in that:Transition-metal catalyst described in step c is selected from palladium, carbon Carry one kind that palladium, nickel, platinum, pallium-on-carbon, carbon are carried during ruthenium, carbon carry rhodium.
11. the method for claim 1, it is characterised in that:Solvent used by step c is selected from water, methyl alcohol, ethanol, positive third In alcohol, isopropanol, the tert-butyl alcohol, tetrahydrofuran, 2- methyltetrahydrofurans, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide At least one.
CN201410038975.3A 2014-01-27 2014-01-27 Method for synthesizing tapentadol hydrochloride Active CN104803861B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410038975.3A CN104803861B (en) 2014-01-27 2014-01-27 Method for synthesizing tapentadol hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410038975.3A CN104803861B (en) 2014-01-27 2014-01-27 Method for synthesizing tapentadol hydrochloride

Publications (2)

Publication Number Publication Date
CN104803861A CN104803861A (en) 2015-07-29
CN104803861B true CN104803861B (en) 2017-05-24

Family

ID=53689113

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410038975.3A Active CN104803861B (en) 2014-01-27 2014-01-27 Method for synthesizing tapentadol hydrochloride

Country Status (1)

Country Link
CN (1) CN104803861B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106674029B (en) * 2016-12-23 2018-08-21 四川久凌制药科技有限公司 A kind of preparation method of tapentadol hydrochloride intermediate
CN107033142A (en) * 2017-05-15 2017-08-11 杭州科耀医药科技有限公司 A kind of synthetic method of Venetoclax key intermediates
ES2951064T3 (en) * 2019-01-15 2023-10-17 Laurus Labs Ltd Preparation procedure of 2-amino-5-hydroxypropiophenone

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1125221A (en) * 1994-07-23 1996-06-26 格吕伦塔尔有限公司 1-Phenyl-3-dimethylaminopropane compounds with pharmacological effects
CN101410390A (en) * 2006-01-17 2009-04-15 先灵公司 Hydantoin compounds for the treatment of inflammatory disorders
CN101495445A (en) * 2006-07-24 2009-07-29 格吕伦塔尔有限公司 Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN102002065A (en) * 2009-09-02 2011-04-06 上海特化医药科技有限公司 Method for preparing tapentadolhydrochloride and intermediate thereof
CN102320984A (en) * 2011-07-25 2012-01-18 江苏恩华药业股份有限公司 Preparation method of (R)-3-(3-methoxy phenyl)-N,N,2-trimethylpent-3-ene-1-amine
WO2012146978A2 (en) * 2011-04-28 2012-11-01 Actavis Group Ptc Ehf A novel process for the preparation of tapentadol or a pharmaceutically acceptable salt thereof
CN102869644A (en) * 2009-12-01 2013-01-09 意优特克股份公司 New process for the preparation of tapentadol and intermediates thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1125221A (en) * 1994-07-23 1996-06-26 格吕伦塔尔有限公司 1-Phenyl-3-dimethylaminopropane compounds with pharmacological effects
CN101410390A (en) * 2006-01-17 2009-04-15 先灵公司 Hydantoin compounds for the treatment of inflammatory disorders
CN101495445A (en) * 2006-07-24 2009-07-29 格吕伦塔尔有限公司 Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN102002065A (en) * 2009-09-02 2011-04-06 上海特化医药科技有限公司 Method for preparing tapentadolhydrochloride and intermediate thereof
CN102869644A (en) * 2009-12-01 2013-01-09 意优特克股份公司 New process for the preparation of tapentadol and intermediates thereof
WO2012146978A2 (en) * 2011-04-28 2012-11-01 Actavis Group Ptc Ehf A novel process for the preparation of tapentadol or a pharmaceutically acceptable salt thereof
CN102320984A (en) * 2011-07-25 2012-01-18 江苏恩华药业股份有限公司 Preparation method of (R)-3-(3-methoxy phenyl)-N,N,2-trimethylpent-3-ene-1-amine

Also Published As

Publication number Publication date
CN104803861A (en) 2015-07-29

Similar Documents

Publication Publication Date Title
CN102395561A (en) Processes for the synthesis of bazedoxifene acetate and intermediates thereof
US7179944B2 (en) Process for preparation of phenethylamine derivatives
CN101654445A (en) Compound for preparing ramelteon, preparation method and application thereof
KR20110015449A (en) Synthesis of Arformoterol
CN102307845B (en) Process for preparing cinacalcet hydrochloride
CN104803861B (en) Method for synthesizing tapentadol hydrochloride
CN102557851B (en) New method for synthesizing tapentadol hydrochloride and analogue of tapentadol hydrochloride
CN102869644A (en) New process for the preparation of tapentadol and intermediates thereof
CN102391220A (en) Tricyclic ethanol compound, as well as preparation method and usages thereof
CN105693603A (en) Improved indacaterol maleate preparation technology
CN104610076B (en) A kind of S-dapoxetine and the synthetic method of salt thereof
WO2012038974A1 (en) Process for preparing l-phenyl-3-dimethylaminopropane derivative
CN102548955B (en) Process for preparing cinacalcet
CN101481333A (en) Novel rivastigmine preparation
CN102786441B (en) Preparation method of rivastigmine, intermediates and preparation method of intermediates
WO2014064706A1 (en) Processes for the preparation of agomelatine using novel intermediates
WO2009086705A1 (en) Preparation method of rivastigmine, its intermediates and preparation method of the intermediates
CA2511683C (en) An efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers
JP3982991B2 (en) Process for producing optically active 1- (trifluoromethylmono-substituted phenyl) ethylamine
US20100094055A1 (en) Process for the preparation of phenethylamine derivatives
US7485754B2 (en) Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers
CN103044274A (en) Method for synthesizing tolterodine tartrate without solvent
CN115925562B (en) A kind of preparation method of salbutamol sulfate
CN102936205A (en) Synthesis method of tapentadol
CN102617528B (en) Tricyclic acetate compound with optical activity, and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20230417

Address after: 226126 No. 100, Dongtinghu Road, Linjiang Town, Haimen District, Nantong City, Jiangsu Province

Patentee after: Haitang (Jiangsu) Biomedical Technology Co.,Ltd.

Address before: Room 306, Building 1, No. 526 Ruiqing Road, Zhangjiang High tech Industry East Zone, Pudong New Area, Shanghai, January 2012

Patentee before: SHANGHAI BIOBOND PHARMACEUTICAL Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20250717

Address after: 200000 Shanghai Pudong New Area Ruiqing Road 526, Building 1, Room 306

Patentee after: SHANGHAI BIOBOND PHARMACEUTICAL Co.,Ltd.

Country or region after: China

Address before: 226126 No. 100, Dongtinghu Road, Linjiang Town, Haimen District, Nantong City, Jiangsu Province

Patentee before: Haitang (Jiangsu) Biomedical Technology Co.,Ltd.

Country or region before: China